Denali Natural Products — TTAB Proceedings
Denali Natural Products is a party to 2 TTAB proceedings.
Proceedings
- Proceeding 91301068 — Oppositions, Terminated (filed 2025-08-17) against Denali Therapeutics Inc. as defendant
- Proceeding 98366342 — Extensions of Time to Oppose, Terminated (filed 2025-03-17) against Denali Therapeutics Inc. as defendant
Marks in These TTAB Matters
- DENALI NATURAL PRODUCTS — proceeding 91301068 (Defendant)
- DENALI NATURAL PRODUCTS — proceeding 98366342 (Defendant)
Common TTAB Counterparties
- Denali Therapeutics Inc. — 2 proceedings
Recent TTAB Timeline
- 2026-03-11: 91301068 — TERMINATED involving Denali Therapeutics Inc.
- 2026-03-11: 91301068 — BOARD'S DECISION: SUSTAINED involving Denali Therapeutics Inc.
- 2026-03-10: 91301068 — WITHDRAWAL OF APPLICATION involving Denali Therapeutics Inc.
- 2026-01-20: 91301068 — SUSPENDED involving Denali Therapeutics Inc.
- 2026-01-20: 91301068 — D MOT TO SUSP W/ CONSENT PEND SETTL NEGOTIATIONS involving Denali Therapeutics Inc.
- 2025-11-06: 91301068 — SUSPENDED involving Denali Therapeutics Inc.
- 2025-11-06: 91301068 — D MOT TO SUSP W/ CONSENT PEND SETTL NEGOTIATIONS involving Denali Therapeutics Inc.
- 2025-09-15: 91301068 — EXTENSION OF TIME GRANTED involving Denali Therapeutics Inc.
- 2025-09-15: 91301068 — D'S MOT FOR EXTEN. OF TIME W/ CONSENT involving Denali Therapeutics Inc.
- 2025-08-17: 98366342 — P CHANGE OF CORRESP ADDRESS involving Denali Therapeutics Inc.
- 2025-08-17: 91301068 — PENDING, INSTITUTED involving Denali Therapeutics Inc.
- 2025-08-17: 91301068 — NOTICE AND TRIAL DATES SENT; ANSWER DUE: involving Denali Therapeutics Inc.
- 2025-08-17: 91301068 — FILED AND FEE involving Denali Therapeutics Inc.
- 2025-06-09: 98366342 — EXTENSION OF TIME GRANTED involving Denali Therapeutics Inc.
- 2025-06-09: 98366342 — FINAL 60-DAY REQUEST TO EXT TIME TO OPPOSE involving Denali Therapeutics Inc.
- 2025-03-17: 98366342 — EXTENSION OF TIME GRANTED involving Denali Therapeutics Inc.
- 2025-03-17: 98366342 — FIRST 90-DAY REQUEST TO EXT TIME TO OPPOSE involving Denali Therapeutics Inc.